Aligos Therapeutics, Inc. (ALGS) vs aTyr Pharma, Inc. (ATYR)
A side-by-side comparison of Aligos Therapeutics, Inc. and aTyr Pharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALGS
Aligos Therapeutics, Inc.
$5.26HealthcareDelayed quote: Oct 6, 2026, 10:04 AM EDT
ATYR
aTyr Pharma, Inc.
$0.29HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
Total return — ALGS vs ATYR
growth of $100 · dividends reinvested · last 2yALGS -63.4% (-39.5%/yr)ATYR -83.2% (-59.1%/yr)ALGS compounded faster over this window
ALGS ATYR
ALGS vs ATYR: by the numbers
- •ALGS is the larger company ($33M vs $29M market cap).
- •Both run net losses; ALGS's is the smaller (-241.01% vs -32003.68% net margin).
- •Both shrank revenue over the past five years; ALGS's decline was smaller (-15.85% vs -38.74% CAGR).
Metrics side by side
Valuation
| Metric | ALGS | ATYR |
|---|---|---|
| P/S ratio | 1.03 | 151.05 |
| P/B ratio | 1.02 | 0.59 |
Profitability
| Metric | ALGS | ATYR |
|---|---|---|
| Gross margin | 57.46% | -717.37% |
| Operating margin | -4024.93% | -40856.32% |
| Net margin | -241.01% | -32003.68% |
| ROE | -238.24% | -124.64% |
| ROIC | -207.97% | -109.29% |
Growth (annualized)
| Metric | ALGS | ATYR |
|---|---|---|
| Revenue CAGR (5Y) | -15.85% | -38.74% |
| Total return CAGR (5Y) | -57.15% | N/A |
Frequently asked
- Which has grown faster, ALGS or ATYR?
- Neither grew: over the past five years both shrank revenue, with ALGS's decline the smaller — ALGS at a -15.85% CAGR versus ATYR at -38.74%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.